Pharvaris PHVS
NASDAQ PHVS
$31.01 -0.71 (-2.24%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pharvaris (PHVS) Short-term Investments (2021 - 2025)

Updated

Pharvaris (PHVS) recorded Short-term Investments of $302.8 million in Q4 2025, up 18.4% from $255.8 million a year earlier.

Analysis

Pharvaris (PHVS) Short-term Investments (2021 - 2025) Analysis & Trends

At the end of FY2025, Pharvaris reported Short-term Investments of $293.89 million, up 13.4% from FY2024.

  • Annual Short-term Investments has a four-year compound annual growth rate of 168.7% (FY2021 to FY2025).
  • Across earlier years, Short-term Investments came in at $259.09 million in FY2024 (-33.8%), $391.37 million in FY2023 (+175.7%), $141.95 million in FY2022 and $5.64 million in FY2021.
  • The Q4 2025 figure is the highest quarterly Short-term Investments since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pharvaris 2.07 Bn -289,124.33 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 302.80 Mn
Dec 31, 2024 255.80 Mn
Dec 31, 2023 389.28 Mn
Dec 31, 2022 137.41 Mn
Dec 31, 2021 5.45 Mn
API Access

Pharvaris Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=PHVS&period=max&api_key=YOUR_API_KEY